Dosimetry & toxicity comparison between CBCT-Guided and MR-Guided Prostate Ultra-hypofractionated RT

被引：0
|
作者：
Kong, V. [1 ]
Padayachee, J. [1 ]
Dang, J. [1 ]
Li, W. [1 ]
Malkov, V. [1 ]
Winter, J. [1 ]
Navarro, I. [1 ]
Berlin, A. [1 ]
Helou, J. [1 ]
Raman, S. [1 ]
Chung, P. [1 ]
机构：
[1] Princess Margaret Canc Ctr, Radiat Med Program, Toronto, ON, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2022年 / 170卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OC-0952
引用
收藏
页码：S844 / S845
页数：2
相关论文
共 50 条
  • [1] Quantitative Relaxometry for Ultra-Hypofractionated MR-Guided Radiotherapy to the Prostate and DIL: A Feasibility Study
    Subashi, E.
    LoCastro, E.
    Brennan, V.
    Apte, A.
    Zelefsky, M.
    Tyagi, N.
    MEDICAL PHYSICS, 2021, 48 (06)
  • [2] Quantitative Relaxometry for Target Localization and Response Assessment in Ultra-Hypofractionated MR-Guided Radiotherapy to the Prostate and DIL
    Subashi, E.
    LoCastro, E.
    Apte, A.
    Zelefsky, M. J.
    Tyagi, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S33 - S33
  • [3] Limited Toxicity with Ultra-Hypofractionated MR- guided Radiotherapy for Oligometastatic Disease
    Herrera, Robert
    Chuong, Michael D.
    Mittauer, Kathryn E.
    Kaiser, Adeel
    Bassiri-Gharb, Nema
    Hall, Matthew D.
    Alvarez, Diane
    La Rosa, Alonso
    Kutuk, Tugce
    Rubens, Muni
    Olorunlogbon, Oreoluwa
    Rzepczynski, Amy E.
    McAllister, Nicole C.
    Tolakanahalli, Ranjini
    Mehta, Minesh P.
    Gutierrez, Alonso N.
    Kotecha, Rupesh
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1867 - S1868
  • [4] Feasibility of Adapt-To-Position Treatment of Prostate Patients Undergoing Ultra-Hypofractionated MR-Guided Adaptive Radiotherapy
    Burleson, S.
    Brennan, V.
    Zelefsky, M.
    Tyagi, N.
    MEDICAL PHYSICS, 2021, 48 (06)
  • [5] Prostate cancer ultra-hypofractionated RT: Does MRI-guided adaptation improve therapeutic ratio?
    Alexander, Sophie E.
    Mitchell, Robert A.
    Morrison, Kian
    Nartey, Jayde
    Westley, Rosalyne
    Oelfke, Uwe
    McNair, Helen A.
    Tree, Alison C.
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S6018 - S6021
  • [6] Prostate cancer - Advantages and disadvantages of MR-guided RT
    Murray, Julia
    Tree, Alison C.
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2019, 18 : 68 - 73
  • [7] Dosimetric comparison of conventionally and ultra-hypofractionated RT boost in prostate cancer
    Krawczyk, J.
    Ginter, A.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1676 - S1676
  • [8] A DOSIMETRIC COMPARISON BETWEEN TRANSLATIONAL CORRECTION WITH CBCT-GUIDANCE AND ADAPTATION USING MR-LINAC FOR PROSTATE ULTRA-HYPOFRACTIONATED RADIOTHERAPY
    Kong, Vickie
    Dang, Jennifer
    Li, Winnie
    Bayley, Andrew
    Berlin, Alejandro
    Helou, Joelle
    Navarro, Inmaculada
    Padayachee, Jerusha
    Raman, Srinivas
    Catton, Charles
    Warde, Padraig
    Winter, Jeff
    Tadic, Tony
    Chung, Peter
    RADIOTHERAPY AND ONCOLOGY, 2021, 163 : S65 - S65
  • [9] Changes in Prostate Volume and Dosimetry with Stereotactic MR-Guided Adaptive Radiotherapy
    Huynh, E.
    Williams, C.
    Han, Z.
    Singer, L.
    Huynh, M.
    Mak, R.
    Cagney, D.
    Leeman, J.
    MEDICAL PHYSICS, 2021, 48 (06)
  • [10] Comparison of CT-guided and MR-guided HDR brachytherapy for prostate cancer
    Haverkamp, U
    Prümer, BA
    Krause, K
    Tschuschke, C
    Blumberg, J
    Benkel, P
    Fischedick, AR
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 118 - 119
12345